DNB Carnegie acted as sole bookrunner to Integrum’s in the fully guaranteed rights issue of approximately SEK 43 million.
Integrum has developed the OPRA® Implant System that allows amputees to directly attach a prosthesis to the bone and musculoskeletal system, therefore avoiding the need for a socket. Based on osseointegration, the bone-anchored implant system offers a range of benefits, including improved mobility and function, enhanced comfort, reduced pressure, a stable attachment and more.